Olio Pharmaceuticals (Olio) is a Bio-pharmaceutical company that has several programs under development for the treatment of diabetes and prostate cancer. The portfolio of products ranging from proprietary drugs to a dieting method and novel line of food products. OLIO’s mission is aimed at the development and marketing of its proprietary products as novel therapeutic approaches for the benefits of patients as well as to create value for partners and investors.By adding nutraceuticals and diabetic oriented food products to their portfolio they provide a wide spectrum solution for patients and stable base for their shareholders.